The antiparkinsonian agent budipine is an N-methyl-D-aspartate antagonist
Data up to Jan 2025
Total Citations Per Year
Abstract
References (19)
Quinoxalinediones: Potent Competitive Non-NMDA Glutamate Receptor Antagonists
1988 • 1,202 citations
Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists
1991 • 554 citations
The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice
1989 • 426 citations
MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.
1988 • 302 citations
NMDA antagonists potentiate antiparkinsonian actions of <scp>L</scp>‐dopa in monoamine‐depleted rats
1990 • 285 citations
Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats
1989 • 168 citations
Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-Dopa in models of Parkinson's disease
1991 • 135 citations
Modulation of the seizure threshold for excitatory amino acids in mice by antiepileptic drugs and chemoconvulsants.
1993 • 64 citations
Differential effects of the excitatory amino acid antagonists, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and 3-((±)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP), on spinal reflex activity in mice
1990 • 43 citations
Adjuvant treatment of Parkinson's disease with budipine: a double-blind trial versus placebo
1987 • 32 citations
Intracerebroventricular administration of 1-methyl-4-phenylpyridinium ion in mice: Effects of simultaneously administered nomifensine, deprenyl, and 1-t-butyl-4,4-diphenylpiperidine
1988 • 25 citations
Clinical Experiences with Budipine in Parkinson Therapy
1985 • 20 citations
[Summarizing description of the pharmacology of budipine, a new 4,4-diphenylpiperidine derivative used in Parkinson therapy (author's transl)].
1982 • 19 citations
Pharmacokinetics and Metabolism of Budipine in Animals and Humans
1985 • 13 citations
[Modification of Parkinson tremor by budipine. A comparative study with amantadine].
1986 • 9 citations
Biochemical and Pharmacologic Aspects of the Mechanism of Action of Budipine
1985 • 9 citations
Budipine: A New Chemical Substance in the Treatment of Parkinson’s Disease
1985 • 9 citations
The Pharmacodynamics of Budipine on Central Neurotransmitter Systems
1985 • 9 citations
Pharmacologic Bases of Antiparkinsonian Therapy
1985 • 7 citations
Cited By (0)
No citing papers found in database